Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Cytrellis Biosystems logo

Cytrellis Biosystems

Recent Finacing

Series C

Recent Raise

$50M

Cytrellis Biosystems is a medical technology company that commercializes the FDA‑cleared ellacor™ Micro‑Coring™ system to remove sagging facial skin without surgery or scarring, indicated for adults 22+ (Fitzpatrick I–IV).

Founded 2012
Massachusetts, United States
11-50
Private
cytrellis.com

Highlights

Focus Areas

Biotechnology
Health Care
Medical

Recent Investors

ARCH Venture Partners logo
Merz logo
Sands Capital logo
PFM Health Sciences logo
D1 Capital Partners logo
Partner Fund Management logo
Biomatics Capital logo

Financials

$78.5M

Total Raised

3

Funding rounds

7

Investors


Team

Upgrade to view the team

See the team members at Cytrellis Biosystems.